Paul Johnson is an Operating Partner at ARTIS Ventures.

Paul founded Artis portfolio company Lemonaid Health in 2014. Lemonaid is recognized as the first national direct to consumer telehealth and telepharmacy provider and helped millions of patients get access to innovative healthcare. Lemonaid launched the first app allowing women to get access to birth control without a doctor visit, the first national online mental health treatment service during COVID-19 and the first asthma, blood pressure and high cholesterol D2C management service. As CEO, Paul led Lemonaid to a $400M exit to 23andMe in 2021, where he then ran the $270M consumer P&L as General Manager and COO for two years.

Prior to Lemonaid, Paul ran large marketing budgets ($100M+) and P&Ls ($200M+) for organizations such as McKesson in the UK. Paul started his first business aged 15 and while at university launched a D2C and B2B digital marketing agency. Since leaving 23andMe in 2023 Paul has been an advisor to healthcare companies, a CEO coach and has sat on public and private boards as an independent board director. Paul has been an advisor to Artis since 2021 and in 2024 became a Operating Partner. In this role Paul supports many of the Artis portfolio companies and represents Artis as a board director of Eko Health.

Paul graduated from The University of Worcester in the UK with a BSc in Computer Science and Business Management.